LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT
Clinical trials for LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT trials appear
Sign up with your email to follow new studies for LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to train immune system to fight blood cancer
Disease control Recruiting nowThis study is testing a new combination of two immune-based drugs, epcoritamab and rituximab, for people with follicular lymphoma who have not yet received any treatment. The goal is to see how well and how safely this drug pair works to control the cancer. About 100 participants…
Matched conditions: LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Researchers track daily life impact of cancer care on seniors
Knowledge-focused Recruiting nowThis study aims to understand how standard treatments for slow-growing lymphoma affect the quality of life of patients aged 70 and older. Researchers will observe 150 patients receiving treatments like immunotherapy or radiation, tracking their well-being through questionnaires b…
Matched conditions: LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC